Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q9UIJ5 (
Rec
)
58,342
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We isolated a novel infectious murine leukemia virus (HoMuLV) from the wild mouse Mus hortulanus. HoMuLV has an ecotropic virus host range, but the viral DNA fails to hybridize to viral envelope segments specific for the known inbred and wild mouse ecotropic as well as nonecotropic MuLVs. Despite this difference in its env gene, HoMuLV appears to use the same ecotropic cell-surface receptor since it infects only hamster and mouse somatic cell hybrids which contain the
Rec
-1 ecotropic virus receptor on chromosome 5. Furthermore, HoMuLV does not infect mice carrying the Fv-4r allele which is thought to prevent ecotropic virus infection through an interference mechanism. HoMuLV is NB-tropic and, unlike other infectious MuLVs, does not grow in cells derived from the wild mouse species. M. dunni. Five to ten months after neonatal inoculation with HoMuLV, 72% of female NIH Swiss mice (8/11) contracted lymphoma or erythroid leukemia, but 33% of the inoculated males (5/15) developed erythroid or myelogenous leukemia within 8-16 months. These data suggest that NIH Swiss males and females differ in their susceptibility to HoMuLV-induced disease. Furthermore, NIH Swiss mice were found to be more susceptible to HoMuLV-induced disease than NFS/N mice. Tumors contained infectious
MCF
virus, which is consistent with the hypothesis that
MCF
virus may mediate tumorigenesis by HoMuLV.
...
PMID:HoMuLV: a novel pathogenic ecotropic virus isolated from the European mouse, Mus hortulanus. 284 96
Malignant catarrhal fever
is briefly reviewed and recent findings are described. Initially the disease was observed as a disease of cattle in Europe where, although no cause could be identified, circumstantial evidence implicated sheep as a source of infection and it was thus designated 'sheep-associated' malignant catarrhal fever. Subsequently the disease was observed in Africa where it became evident that a herpesvirus which normally infects wildebeest was the cause. It is now apparent that deer are highly susceptible to both forms of the disease, the sheep-associated form being a serious problem in farmed deer. The wide spectrum of clinical and pathological changes that occur in affected deer are described. A major constraint to studies of sheep-associated malignant catarrhal fever has been the absence of an experimental laboratory system. However, from affected deer it has been possible to transmit the disease to rabbits and thus has allowed detailed pathogenesis studies to be made which are summarised in this paper. It is suggested that the agent of sheep-associated malignant catarrhal fever is a virus and that when a particular subpopulation of T-lymphocytes is infected a profound immunological perturbation results; the lesions of malignant catarrhal fever being explained by a benign T-lymphocyte hyperplasia accompanied by a deregulation of cytotoxic natural killer lymphocytes that gives rise to tissue necrosis.
Vet
Rec
1984 Jun 16
PMID:Malignant catarrhal fever. 643 86
Malignant catarrhal fever
virus was not isolated from samples of fetal membranes or fluid collected from 93 calving wildebeest (Connochaetes taurinus) in Kenya Maasailand. Cell-free strains of malignant catarrhal fever virus were very rapidly inactivated when exposed to the sun under field conditions, at least 3.0 log10 units/25 microliter being lost per hour at midday. It is suggested that wildebeest fetal membranes and fluids act as visual markers for areas of pasture which are particularly heavily contaminated with malignant catarrhal fever virus in oculonasal secretions of wildebeest calves. It is possible that starting to graze cattle one to two hours later each morning may be a useful measure for helping to protect cattle from malignant catarrhal fever in areas where they are forced to share pastures with calving wildebeest.
Vet
Rec
1983 Aug 13
PMID:Role of wildebeest fetal membranes and fluids in the transmission of malignant catarrhal fever virus. 662 72
Malignant catarrhal fever
(
MCF
) is traditionally regarded as a disease with a short clinical course, low morbidity and high case fatality rate. Owing to the limitations of the assays used for laboratory diagnosis. It was difficult in characterise the clinical spectrum of sheep-associated
MCF
, particularly when the cattle recovered from an
MCF
-like clinical syndrome. Over a period of three years, 11 cattle that survived
MCF
for up to two-and-a-half years were identified on four premises. A clinical diagnosis of
MCF
was confirmed by the detection of ovine herpesvirus-2 DNA in peripheral blood leucocytes using a polymerase chain reaction (PCR) assay that detects a specific 238 base-pair fragment of viral genomic DNA. Of the 11 cattle examined, six recovered clinically with the exception of bilateral corneal oedema with stromal keratitis (four animals) and unilateral perforating keratitis (one animal). The 10 animals available for postmortem examination had disseminated subacute to chronic arteriopathy. Recovery was associated with the resolution of the acute lymphoid panarteritis that characterises the acute phase of
MCF
, and with the development of generalised chronic obliterative arteriosclerosis. Bilateral leucomata were due in part to the focal destruction of corneal endothelium secondary to acute endothelialitis. Formalin-fixed tissues and/or unfixed lymphoid cells from all 11 cattle were positive for sheep-associated
MCF
by PCR. These observations indicate that recovery and chronic disease are a significant part of the clinical spectrum of
MCF
and that such cases occur with some frequency in the area studied. The affected cattle remain persistently infected by the putative sheep-associated
MCF
gammaherpesvirus.
Vet
Rec
1997 May 17
PMID:Chronic and recovered cases of sheep-associated malignant catarrhal fever in cattle. 953
A longitudinal observational study of 15 red deer farms was carried out in New Zealand for two years from March 1992. The deer were monitored for performance and health problems, and farm management practices were recorded. Numbers at risk were 4,683 hind-years, 2,459 stag-years and 3,202 weaner-years. The numbers of primiparous and adult hinds at risk of losing their progeny by weaning were 653 and 3,364, respectively. Where possible, postmortem examinations were carried out, and organs were sampled for histological and microbiological investigation. Rates of mortality varied with season with most stag and hind deaths in winter and weaner deaths in autumn and winter. Overall mortality rates were 1.77, 2.60 and 5.87 per 100 deer-years for hinds, stags and weaners, respectively.
Malignant catarrhal fever
accounted for 0.53 stag and 0.17 hind deaths per 100 deer-years at risk Misadventure, including broken bones, accounted for 15.4 per cent of weaner mortalities, or 0.53 weaner mortalities per 100 weaner-three months in autumn. Yersiniosis was confirmed in 18.6 per cent of weaner deaths, or 1.09 weaners per 100 weaner-years during the first six months after weaning, but was also suspected but unconfirmed in a further 41 per cent of weaner mortalities. Overall, 17 per cent of yearling hinds, and 9.2 per cent of adult hinds lost their progeny between pregnancy diagnosis in June and weaning in March. One outbreak of osteochondrosis was recorded. Mortality rates varied between farms and many mortalities were preventable.
Vet
Rec
2001 Mar 17
PMID:Disease and mortality on red deer farms in New Zealand. 1131 92
The presence of a live cell cohabiting within another cell has fascinated scientists for many decades. Far from being a spurious event, many have attempted to uncover the molecular mechanism underlying this phenomenon. In this study, we observed anchorage-dependent
MCF
-7 cells internalizing neighboring epithelial cells (entosis) after siRNA-mediated silencing of the Metallothionein-2A (MT-2A) gene. MTs belong to a family of low-molecular weight proteins, which bind metal ions endogenously and its over-expression has been reported in a variety of cancers that include breast, prostate, and colon. We provide microscopic evidence at light and ultrastructural levels of the occurrence of entosis after altering MT expression in a subpopulation of
MCF
-7 breast cancer cells by silencing the MT-2A gene. Our results demonstrate that adheren junctions may play important roles in the formation of cell-in-cell cytostructure after MT-2A gene downregulation and the entotic process does not appear to involve genes associated with autophagy. Interiorized cells often underwent lysosomal degradation within the cytoplasmic body of the engulfing cell. It would appear that a subset of breast cancer cells could die via entosis after MT-2A gene silencing.
Anat
Rec
(Hoboken) 2010 Oct
PMID:Silencing the Metallothionein-2A gene induces entosis in adherent MCF-7 breast cancer cells. 2065 34
The p21-activated kinases have been implicated in the control of cell cycle progression. However, the biological mechanism underlying the role of p21-activated kinase 4 (PAK4) in cell cycle control remains unknown. Here, by using quantitative RT-PCR and immunoblot analyses, we discovered that over-expression of PAK4 could suppress cyclin-dependent kinase inhibitor 1C (p57(Kip2) ) expression in the
MCF
-7 human breast cancer cell line, whereas lentiviral vector-mediated small interfering RNA (siRNA) knockdown of PAK4 markedly promoted p57(Kip2) expression in
MCF
-7 cells. Furthermore, PAK4-mediated down-regulation of p57(Kip2) was reversed by MG132, a specific proteasome inhibitor. The ubiquitination assay confirmed that the activity of PAK4 attenuated p57(Kip2) protein stability through the ubiquitin-proteasome pathway in
MCF
-7 cells. Moreover, a significant inverse correlation between PAK4 and p57(Kip2) protein levels was observed in breast cancer tissues by immunohistochemical analysis. Taken together, our data demonstrate a novel function for PAK4 in regulating the stability of p57(Kip2) , possibly through the ubiquitin-proteasome pathway, leading to increased proliferation of breast cancer cells. Thus, PAK4 may be used as a potential diagnostic and therapeutic target for human breast cancer.
Anat
Rec
(Hoboken) 2013 Oct
PMID:P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer. 2387 32